Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2026)

Ginkgo Bioworks Holdings has reported Shares Outstanding for 8 years, with the latest figure at $65.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 19.08% year-over-year to $65.1 million; the trailing twelve-month figure through Mar 2026 stood at $65.1 million (up 19.08% YoY), and the FY2025 full-year result was $61.7 million, up 13.45% from the prior year.
• Shares Outstanding for Q1 2026 stood at $65.1 million, up from $61.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $2.0 billion in Q2 2023, with the low at $47.3 million in Q4 2022.
• Historically, Shares Outstanding has averaged $555.6 million across 5 years, with a median of $55.4 million in 2025.
• Annual changes were most pronounced in 2022 — Shares Outstanding jumped 403394.57% — and 2024, when it slumped 97.37%.
• Ginkgo Bioworks Holdings' Shares Outstanding stood at $47.3 million in 2022, then rose by 5.78% to $50.0 million in 2023, then grew by 8.66% to $54.4 million in 2024, then increased by 13.45% to $61.7 million in 2025, then increased by 5.6% to $65.1 million in 2026.
• The last three Shares Outstanding figures came in at $65.1 million (Q1 2026), $61.7 million (Q4 2025), and $60.3 million (Q3 2025), per Business Quant data.